- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/45 - Non-condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
Patent holdings for IPC class A61K 31/45
Total number of patents in this class: 554
10-year publication summary
|
19
|
28
|
43
|
46
|
37
|
32
|
39
|
39
|
46
|
26
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Amicus Therapeutics, Inc. | 353 |
19 |
| Celgene Corporation | 1390 |
19 |
| Dana-Farber Cancer Institute, Inc. | 2602 |
11 |
| Bristol-myers Squibb Company | 4840 |
8 |
| Amgen Inc. | 4122 |
7 |
| Novartis AG | 10707 |
6 |
| The Regents of the University of California | 20153 |
6 |
| Boehringer Ingelheim International GmbH | 4644 |
6 |
| H. Lee Moffitt Cancer Center and Research Institute, Inc. | 970 |
6 |
| Bpcr Limited Partnership | 36 |
6 |
| Allergan, Inc. | 2329 |
5 |
| Baylor College of Medicine | 963 |
5 |
| Epizyme, Inc. | 374 |
5 |
| C4 Theraprutics, Inc. | 59 |
5 |
| F. Hoffmann-La Roche AG | 7946 |
4 |
| Hoffmann-La Roche Inc. | 3489 |
4 |
| Genentech, Inc. | 4012 |
4 |
| Board of Regents, The University of Texas System | 5891 |
4 |
| The Johns Hopkins University | 5730 |
4 |
| Beth Israel Deaconess Medical Center, Inc. | 864 |
4 |
| Other owners | 416 |